Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Brugada syndrome].

A Leenhardt1, B Hamdaoui, S Di Fusco

  • 1Service de cardiologie, hôpital Lariboisière, 2, rue Ambroise Paré, 75475 Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|July 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High prevalence of ventricular repolarization abnormalities in people carrying TGFβR2 mutations.

Scientific reports·2018
Same author

Beckwith-Wiedemann syndrome and long QT syndrome due to familial-balanced translocation t(11;17)(p15.5;q21.3) involving the KCNQ1 gene.

Clinical genetics·2012
Same author

[Is atrial fibrillation an independent marker of cardiovascular risk?].

Annales de cardiologie et d'angeiologie·2011
Same author

Influence of blood glucose on heart rate and cardiac autonomic function. The DESIR study.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

Clinical reasoning: seizures in a child with sensorineural deafness and agitation.

Neurology·2010
Same author

[Pathophysiopathology of atrial fibrillation: applications to treatment].

Annales de cardiologie et d'angeiologie·2010
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Brugada syndrome, a genetic heart condition, causes sudden death through arrhythmias in structurally normal hearts. Management strategies are evolving, especially for asymptomatic individuals.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Context:

  • Brugada syndrome presents with syncope or sudden cardiac death in individuals with structurally normal hearts.
  • Electrocardiographic findings include right bundle branch block and ST elevation in right precordial leads (V1-V3).
  • Autosomal dominant inheritance with variable penetrance is characteristic.

Purpose:

  • To review the clinical presentation, genetic basis, and management of Brugada syndrome.
  • To discuss the role of SCN5A gene mutations in sodium channel dysfunction.
  • To propose a decision-making algorithm for managing Brugada syndrome patients.

Summary:

  • Mutations in the SCN5A gene, encoding the sodium channel alpha subunit, are found in approximately 30% of Brugada syndrome cases.

Related Experiment Videos

  • These mutations reduce sodium current density, exacerbating ECG abnormalities with sodium channel blockers.
  • Prognosis is poor for symptomatic patients, necessitating automatic defibrillator implantation; management of asymptomatic cases remains challenging.

    • Impact:

    • Highlights the importance of genetic testing and understanding SCN5A mutations in Brugada syndrome.
    • Emphasizes the need for a structured approach to patient management, particularly in asymptomatic individuals.
    • Suggests that future research will refine therapeutic decisions and improve outcomes for Brugada syndrome patients.